| Nov 6 |
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
|
| Nov 6 |
Tarsus Pharmaceuticals seesaws amid report Alcon interest has cooled
|
| Nov 5 |
Tarsus appoints Elizabeth Yeu as its Chief Medical Officer
|
| Nov 5 |
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
|
| Oct 30 |
Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?
|
| Oct 29 |
Tarsus Pharmaceuticals gains amid takeover speculation
|
| Oct 28 |
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
|
| Oct 18 |
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
|
| Oct 17 |
Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%
|
| Oct 9 |
Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ...
|
